Tennessee 2025-2026 Regular Session

Tennessee House Bill HB1954

Introduced
1/22/26  
Refer
2/4/26  
Refer
2/18/26  
Refer
3/17/26  
Chaptered
4/13/26  

Caption

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine products.

Impact

The passage of HB 1954 is expected to adjust the existing framework governing healthcare provision within correctional systems in Tennessee. By updating the qualifications and stipulations for healthcare providers who facilitate buprenorphine treatments, the bill aims to improve the standards of medical care available to incarcerated individuals. Involving healthcare vendors more directly in the correctional healthcare process is seen as a step towards better management of substance use disorders among inmates, which is crucial for rehabilitation efforts.

Summary

House Bill 1954 is a legislative measure aimed at amending sections of the Tennessee Code Annotated related to buprenorphine products, which are commonly used in the treatment of opioid addiction. The bill focuses on the qualifications necessary for healthcare providers who are involved in delivering these products, particularly within correctional facilities. This change is intended to streamline the provision of healthcare services in jails and prisons, ensuring that qualified personnel are employed or contracted to deliver such care effectively.

Sentiment

Sentiment around HB 1954 has generally been supportive, particularly among legislators focused on addressing the opioid crisis and improving health outcomes for individuals within the correctional system. Many advocates believe that facilitating access to medications like buprenorphine saves lives and helps to mitigate broader public health issues associated with opioid addiction. However, some concern has been voiced regarding the adequacy of training for contractors and the effectiveness of medication management in these environments.

Contention

While the bill has garnered significant support, it has also sparked discussions about the adequacy of healthcare provisions in correctional facilities. Critics have cautioned that merely amending qualification standards may not address deeper systemic issues within the prison healthcare system. There is a call for comprehensive oversight and accountability measures to ensure that these new amendments translate into genuine improvements in access to and quality of healthcare for those involved in the criminal justice system.

Companion Bills

TN SB2549

Crossfiled AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine products.

Previously Filed As

TN SB2549

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine products.

TN SB1848

AN ACT to amend Tennessee Code Annotated, Title 53, Chapter 11, relative to the use of buprenorphine products.

TN HB1984

AN ACT to amend Tennessee Code Annotated, Title 53, Chapter 11, relative to the use of buprenorphine products.

TN HB1205

AN ACT to amend Tennessee Code Annotated, Title 33; Title 39; Title 53; Title 63 and Title 68, relative to healthcare services.

TN HB0192

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to medical treatment.

TN SB0282

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to medical treatment.

TN SB0421

AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.

TN HB1239

AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.

TN SB1949

AN ACT to amend Tennessee Code Annotated, Title 8; Title 14; Title 39; Title 40; Title 53; Title 63 and Title 68, relative to mRNA products.

TN HB0760

AN ACT to amend Tennessee Code Annotated, Title 49; Title 53; Title 63 and Title 68, relative to bronchodilator rescue inhalers.

Similar Bills

No similar bills found.